Israel’s Imagene AI develops fast AI-based cancer diagnostics to help identify personalized treatment. Using a digitized biopsy image, Imagene delivers real-time precision-based molecular analysis, increased accuracy and reducing the time required for results, from several weeks to just two minutes.